Kindly MD (KDLYW) Competitors $2.88 -0.89 (-23.61%) As of 09/16/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock KDLYW vs. AONCW, AONC, PIIIW, TOIIW, ATNFW, SXTPW, ACONW, AIMDW, DRTSW, and ALVOWShould you be buying Kindly MD stock or one of its competitors? The main competitors of Kindly MD include American Oncology Network (AONCW), American Oncology Network (AONC), P3 Health Partners (PIIIW), Oncology Institute (TOIIW), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), and Alvotech (ALVOW). These companies are all part of the "medical" sector. Kindly MD vs. Its Competitors American Oncology Network American Oncology Network P3 Health Partners Oncology Institute 180 Life Sciences 60 Degrees Pharmaceuticals Aclarion Ainos Alpha Tau Medical Alvotech Kindly MD (NASDAQ:KDLYW) and American Oncology Network (NASDAQ:AONCW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings. Which has better earnings and valuation, KDLYW or AONCW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKindly MD$2.47MN/AN/AN/AN/AAmerican Oncology Network$1.34BN/AN/AN/AN/A Does the media prefer KDLYW or AONCW? In the previous week, American Oncology Network had 2 more articles in the media than Kindly MD. MarketBeat recorded 2 mentions for American Oncology Network and 0 mentions for Kindly MD. American Oncology Network's average media sentiment score of 0.99 beat Kindly MD's score of 0.00 indicating that American Oncology Network is being referred to more favorably in the news media. Company Overall Sentiment Kindly MD Neutral American Oncology Network Positive Is KDLYW or AONCW more profitable? Company Net Margins Return on Equity Return on Assets Kindly MDN/A N/A N/A American Oncology Network N/A N/A N/A SummaryAmerican Oncology Network beats Kindly MD on 3 of the 3 factors compared between the two stocks. Get Kindly MD News Delivered to You Automatically Sign up to receive the latest news and ratings for KDLYW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KDLYW vs. The Competition Export to ExcelMetricKindly MDMedical Care Facilities IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.49B$5.76B$10.26BDividend YieldN/A3.82%5.88%4.63%P/E RatioN/A160.5876.5826.64Price / SalesN/A30.35525.00124.82Price / CashN/A12.3237.1760.46Price / BookN/A1.9414.156.31Net IncomeN/A$58.06M$3.29B$271.01M7 Day Performance-28.36%0.01%1.28%2.40%1 Month Performance-81.18%-0.86%5.01%6.77%1 Year Performance893.45%34.96%86.96%27.26% Kindly MD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KDLYWKindly MDN/A$2.88-23.6%N/A+1,300.7%$0.00$2.47M0.0023Gap DownAONCWAmerican Oncology NetworkN/A$1.35-1.5%N/AN/A$0.00$1.34B0.001,525Gap DownAONCAmerican Oncology NetworkN/A$11.00+0.1%N/A+201.1%$0.00$1.34B0.001,520Short Interest ↑PIIIWP3 Health PartnersN/A$0.01-5.6%N/AN/A$0.00$1.46B0.00500Positive NewsGap UpTOIIWOncology InstituteN/A$0.11-0.1%N/A+890.6%$0.00$424.38M0.00660Positive NewsATNFW180 Life SciencesN/A$0.08+9.2%N/A+1,069.2%$0.00N/A0.007Gap UpSXTPW60 Degrees PharmaceuticalsN/A$0.05-5.7%N/A+19.0%$0.00$641.41K0.002Positive NewsGap DownACONWAclarionN/A$0.03+12.0%N/A-13.2%$0.00$62.95K0.007Positive NewsGap DownAIMDWAinosN/A$0.11-18.3%N/A+214.0%$0.00$110.87K0.0040Positive NewsGap DownDRTSWAlpha Tau MedicalN/A$0.30flatN/A+50.9%$0.00N/A0.0080ALVOWAlvotechN/A$0.96-15.0%N/AN/A$0.00$560.10M0.004Positive NewsGap Down Related Companies and Tools Related Companies American Oncology Network Alternatives American Oncology Network Alternatives P3 Health Partners Alternatives Oncology Institute Alternatives 180 Life Sciences Alternatives 60 Degrees Pharmaceuticals Alternatives Aclarion Alternatives Ainos Alternatives Alpha Tau Medical Alternatives Alvotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KDLYW) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kindly MD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kindly MD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
